Hjem › Sigdcelleanemi › Pennsylvania
Kliniske studier for Sigdcelleanemi i Pennsylvania
20 studier for Sigdcelleanemi søker deltakere på steder i Pennsylvania.
Byer i Pennsylvania
Offisiell studietekst (engelsk)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Spoknwrdclinicaltrials, Easton
- Thomas Jefferson University Me, Philadelphia
RekruttererFase 3
Alder 12 til 100 · Alle kjønn · Oppdatert 28. sep. 2026 · NCT06439082A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
- University of Pittsburgh Medical Center (UPMC), Pittsburgh
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT07187973A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Children's Hosptl Philadelphia, Philadelphia
- St Christopher Hosp for Child, Philadelphia
RekruttererFase 3
Alder 12 og eldre · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06612268A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
- Childrens Hospital Of Philadelphia, Philadelphia
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
Alder 12 til 55 · Alle kjønn · Oppdatert 9. sep. 2026 · NCT06546670A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
- Local Institution - 0029, Philadelphia
- Thomas Jefferson University - Medicine/GI and Hepatology, Philadelphia
- Local Institution - 0032, Pittsburgh
RekruttererFase 1/2Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06481306ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Hospital of Philadelphia, Philadelphia
- Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia
- St. Christopher's Hospital for Children, Philadelphia
- og 1 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Pittsburgh, Pittsburgh
- Hillman Cancer Center, Pittsburgh
RekruttererFase 2
Alder 12 og eldre · Alle kjønn · Oppdatert 14. aug. 2026 · NCT06699849T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
RekruttererFase 1/2
Alder 5 til 40 · Alle kjønn · Oppdatert 13. aug. 2026 · NCT03653338Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 1/2
Alder 12 til 45 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT07252050Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Children's Hospital of Philadelphia (MRD-HCT), Philadelphia
RekruttererObservasjonsstudie
Alder 3 til 20 · Alle kjønn · Oppdatert 4. jun. 2026 · NCT06941389Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease
- Children's Hospital of Philadelphia, Philadelphia
RekruttererFase 4
Alder 18 til 50 · Kvinner · Oppdatert 28. mai 2026 · NCT06665997A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
- Children's Hospital of Philadelphia, Philadelphia
Rekrutterer
Alder 13 til 21 · Alle kjønn · Oppdatert 11. mai 2026 · NCT06290401Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
- Children's Hospital of Philadelphia, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
RekruttererFase 2
Alder 15 til 40 · Alle kjønn · Oppdatert 13. mar. 2026 · NCT06260891Stress Management and Mindfulness Intervention for Patients With Sickle Cell Disease
- University of Pennsylvania, Philadelphia
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 27. feb. 2026 · NCT07316478A Long-term Follow-up Study in Patients Who Received BEAM-101
- Children's Hospital of Philadelphia, Philadelphia
RekruttererObservasjonsstudie
Alder 14 til 37 · Alle kjønn · Oppdatert 28. jan. 2026 · NCT07373639Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
RekruttererObservasjonsstudie
2 Months – 60 Years · Alle kjønn · Oppdatert 13. jan. 2026 · NCT04528355Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
- UPMC University of Pittsburgh Classical Hematology Adult Clinic, Pittsburgh
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
Rekrutterer
Alder 16 til 30 · Alle kjønn · Oppdatert 7. jan. 2026 · NCT06374238Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT
- UPMC Children's Hospital of Pittsburgh, Pittsburgh
RekruttererFase 2
2 Months – 55 Years · Alle kjønn · Oppdatert 15. des. 2025 · NCT01962415Cutaneous Hydration Assessment in SCD
- UPMC Sickle Cell Clinic, Pittsburgh
Rekrutterer
Alder 12 og eldre · Alle kjønn · Oppdatert 12. nov. 2025 · NCT05210114Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
- University of Pennsylvania, Philadelphia
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 22. jun. 2025 · NCT06385886Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.